KPV
KPV is a potent anti-inflammatory tripeptide derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH).
Also known as: Anti-Inflammatory Tripeptide, Alpha-MSH Fragment
Overview
KPV is a potent anti-inflammatory tripeptide derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). This small but powerful peptide exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH. KPV has shown particular promise for inflammatory bowel diseases, skin conditions, and immune modulation through its ability to penetrate cells and interact directly with inflammatory signaling pathways.
Key Benefits
- Systemic Inflammation
- Autoimmune Modulation
- Joint Inflammation
Systemic anti-inflammatory effects, immune modulation, potential for autoimmune conditions
Mechanism of Action
Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling
Pharmacokinetics
Peak plasma concentration: 3 min. Elimination half-life: 30 min. Largely cleared by: ~2.5 hrs.
Research Protocols Injectable
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General Anti-Inflammatory | 200-300mcg | Once daily | Subcutaneous |
| Active Inflammation | 250mcg | Twice daily | Subcutaneous |
| Autoimmune Support | 500mcg | Once daily | Subcutaneous |
| Acute Flare-ups | 500mcg | Twice daily for 1 week then reduce | Subcutaneous |
Research protocols from published literature — not dosing recommendations.
Peptide Interactions
- BPC-157 — Synergistic: Complementary gut healing mechanisms - BPC-157 promotes tissue repair while KPV reduces inflammation
- TB-500 — Compatible: Both have anti-inflammatory properties through different pathways - may work well together
- LL-37 — Synergistic: Both are antimicrobial peptides - KPV focuses on inflammation while LL-37 on direct antimicrobial action
- Thymosin Alpha-1 — Compatible: Different immune modulation mechanisms - TA1 enhances immune function while KPV reduces inflammation
- GHK-Cu — Synergistic for Skin: Excellent combination for skin health - GHK-Cu promotes collagen while KPV reduces inflammation
- Melanotan II — Use Caution: KPV is derived from α-MSH like MT-II but without tanning effects - using both is unnecessary
Peptide Instructions Injectable
Supplies:
- KPV peptide vial
- Bacteriostatic water
- Insulin syringes
- Alcohol prep pads
How to Reconstitute Injectable
- 1Clean vial top with alcohol pad
- 2Add 1mL bacteriostatic water to 1mg vial (creates 1000mcg/mL)
- 3For easier dosing: Add 2mL to 1mg vial (creates 500mcg/mL)
- 4Gently swirl to mix - KPV dissolves easily
- 5Solution should be clear and colorless
- 6Label with concentration and date
What to Expect Injectable
Day 1-3: Subtle reduction in inflammation, improved energy. Week 1: Noticeable decrease in inflammatory symptoms. Week 2-3: Improved gut function, reduced pain/swelling. Week 4: Significant improvement in target condition. Week 6-8: Sustained anti-inflammatory benefits, improved quality of life.
Side Effects & Safety
Excellent safety profile with minimal side effects. Does not cause immunosuppression like steroids. No melanin production or tanning effects. May temporarily reduce inflammation-related symptoms. Monitor for signs of infection (rare). Generally well-tolerated even at higher doses.
Excellent safety profile with minimal side effects. Does not cause immunosuppression like steroids. No melanin production or tanning effects. May temporarily reduce inflammation-related symptoms. Monitor for signs of infection (rare). Generally well-tolerated even at higher doses.
Community Insights
KPV should be stored at Refrigerate after reconstitution, stable for 30-45 days.
References
- Antimicrobial Properties Against Gut Pathogens (2022)
- KPV for Psoriasis and Dermatitis (2021)
- Anti-Inflammatory Mechanisms of KPV (2020)
- KPV in Inflammatory Bowel Disease Models (2019)
Research reference only. Not medical advice.